Jonathan Mayer v. ADCS Clinics, LLC, et al.

CourtDistrict Court, E.D. Pennsylvania
DecidedDecember 9, 2025
Docket2:21-cv-05303
StatusUnknown

This text of Jonathan Mayer v. ADCS Clinics, LLC, et al. (Jonathan Mayer v. ADCS Clinics, LLC, et al.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jonathan Mayer v. ADCS Clinics, LLC, et al., (E.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

JONATHAN MAYER, : CIVIL ACTION Plaintiff-Relator, : : v. : : ADCS CLINICS, LLC, et al., : No. 21-cv-5303 Defendants. :

MEMORANDUM KENNEY, J. December 9, 2025 The Court writes for the benefit of the Parties and assumes familiarity with the facts of the case. Previously, this Court granted in part and denied in part Relator’s Motion to Strike the report of Defendants’ expert Troy A. Barsky, and it afforded Defendants a limited period to revise and resubmit the report solely to address improper legal opinions that the report contained. See ECF No. 253 at 1. Relator now moves to strike the revised Barsky Report (ECF No. 262). For the reasons set forth below, Relator’s Motion (ECF No. 262) will be DENIED except as to the portion of paragraph 57 of the revised Barsky Report identified below. I. DISCUSSION A. Relator’s Renewed Argument that Mr. Barsky Opines on Legal Conclusions After this Court previously directed Defendants to remedy deficiencies in the Barsky Report, see ECF No. 253 at 1, Defendants submitted a revised Barsky Report, see generally ECF No. 264-2. The revised report was fifteen pages shorter than the original report, and it included a number of revisions, deletions, and insertions. Compare, e.g., ECF No. 246-3 ¶ 19, with ECF No. 264-2 ¶ 20; ECF No. 246-3 ¶¶ 34–38, with ECF No. 264-2 ¶¶ 34–35; ECF No. 246-3 ¶¶ 41–43, with generally ECF No. 264-2. The Court engaged in a careful page-by-page comparison of the original and revised Barsky Reports, and the revisions suggest a good-faith effort by Defendants to comply with the Court’s prior ruling.1 Relator moves to strike the revised Barsky Report because it contains legal conclusions. See ECF No. 262-1 at 17; ECF No. 264 at 17. The Court discussed the framework governing this issue when ruling on Relator’s previous motion to strike, and it incorporates that analysis here. See ECF No. 252 at 6–8; ECF No. 254 at 6–8. As explained in greater detail in the Court’s prior

opinion, though experts may sometimes give background testimony on regulatory schemes and their requirements, they generally cannot opine on “pure issues of law,” Antrim Pharms. LLC v. Bio-Pharm, Inc., 950 F.3d 423, 430 (7th Cir. 2020), or render ultimate legal conclusions regarding a party’s liability, Patrick v. Moorman, 536 F. App’x 255, 258 (3d Cir. 2013). Experts may also testify about industry customs and practices. In re Puda Coal Secs., Inc., 30 F. Supp. 3d 230, 251– 52 (S.D.N.Y. 2014), aff’d sub nom., Querub v. Hong Kong, 649 F. App’x 55 (2d Cir. 2016). The revised Barsky Report generally falls on the permissible side of this divide. A number of the statements with which Relator takes issue provide background on the Stark Law—for instance, identifying exceptions to the Stark Law, see, e.g., ECF No. 264-2 ¶¶ 17, 45, 58. See

United States v. Duncan, 42 F.3d 97, 101 n.3 (2d Cir. 1994) (witness appropriately explained “sophisticated aspects” of federal tax system); United States v. Bilzerian, 926 F.2d 1285, 1294–95 (2d Cir. 1991) (no abuse of discretion to allow expert to provide background on securities regulation, particularly given that a limiting instruction was used); United States v. Onyenso, 615 F. App’x 734, 738 (3d Cir. 2015) (witness could testify to purpose of Anti-Kickback Statute). These statements differ from those with which the Court previously took issue, which, when

1 Relator argues that “much of what Defendants removed” from the Barsky Report was the “mass copying and pasting of the [text of the] Stark Law.” ECF No. 266 at 5. Though there are some Stark Law excerpts that were removed from the Barsky Report, see, e.g., ECF No. 246-3 ¶ 68, the Court’s comparison of the original and revised reports reveals that Mr. Barsky made meaningful revisions to his report and that these revisions were not limited merely to deleting excerpts of the Stark Law, as discussed above. viewed together, made legal arguments about the meaning of Stark Law terms and CMS regulations. See ECF No. 254 at 7; see also Antrim Pharms. LLC, 950 F.3d at 430 (experts typically cannot opine on “the meaning of statutes or regulations,” given that it is the court’s role to instruct the jury on the law); United States v. Offill, 666 F.3d 168, 175 (4th Cir. 2011). The scope of Mr. Barsky’s background testimony on Stark Law may be appropriately policed at trial.2 See Pension

Comm. of the Univ. of Montreal Pension Plan v. Banc of Am. Secs., LLC, 691 F. Supp. 2d 448, 471 (S.D.N.Y. 2010). Other statements made by Mr. Barsky respond to the legal commentary of Relator’s own experts, see, e.g., ECF No. 264-2 ¶¶ 43–46. For instance, Mr. Barsky responds to a statement made by Relator’s expert Todd Zigrang that there are “three tenets of defensibility” under the Stark Law. See, e.g., id. ¶ 43; see also ECF No. 246 at 18; cf. also ECF No. 264-2 ¶ 46 (rebutting Mr. Zigrang’s reliance on compensation surveys). Relator argues that the Court labeled Mr. Zigrang’s statement a “passing remark” in ruling on Relator’s first Motion to Strike. See ECF No. 266 at 4. That is not quite so. What the Court found was a passing remark was Mr. Zigrang’s footnote briefly stating

that commercial reasonableness was one such tenet. See ECF No. 254 at 3. And the Court made this comment when deciding whether Mr. Zigrang opened the door to a rebuttal report calculating the commercial reasonableness of certain compensation arrangements—a very different issue than the one presented here. See id. However, to the extent Mr. Zigrang’s report states there are three core elements to satisfying the Stark Law, and identifies what those tenets are, Mr. Barsky may address this remark and similar remarks as incorrect or incomplete at the expert report stage.3

2 Other parts of Mr. Barsky’s testimony involve mixed questions of law and fact, including hypotheticals. See, e.g., ECF No. 264-2 ¶ 10; see Offill, 666 F.3d at 177. To the extent these hypotheticals are prejudicial or too closely parallel the facts of this case, those issues can also be policed at trial. 3 Similarly, Relator argues that rather than rebut only his experts, Mr. Barsky attempts to rebut Relator’s own legal theories. See ECF No. 264 at 7. But Relator’s experts make certain This is not to say that the Court will permit Mr. Barsky to use the guise of experience, or other runarounds, to offer impermissible legal testimony. See ECF No. 264 at 6–8. The Court will strike one statement in Mr. Barsky’s revised report on this basis. Mr. Barsky opines that based on “advis[ing] a wide range of health care clients” and analyzing clients’ arrangements, he “understand[s] [the term] ‘directly supervised’ [in the in-office ancillary services exception of the

Stark Law] to mean the supervision required under applicable Medicare payment or coverage rules for the specific services at issue.” ECF No. 264-2 ¶ 57. This sentence goes beyond offering mere regulatory background, providing context for his opinions, or testifying about industry practices and customs. Instead, Mr. Barsky engages in acts of statutory interpretation, couched in his experience of advising healthcare clients in his current practice as a regulatory lawyer. See id. Should this case proceed to trial, the Court will also not permit Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Paul A. Bilzerian
926 F.2d 1285 (Second Circuit, 1991)
United States v. Offill
666 F.3d 168 (Fourth Circuit, 2011)
United States v. Vinal S. Duncan
42 F.3d 97 (Second Circuit, 1994)
Dustin Patrick v. Michael Moorman
536 F. App'x 255 (Third Circuit, 2013)
In Re Initial Public Offering Securities Litigation
174 F. Supp. 2d 61 (S.D. New York, 2001)
United States v. Chikezie Onyenso
615 F. App'x 734 (Third Circuit, 2015)
Paula Babb v. Maryville Anesthesiologists, P.C.
942 F.3d 308 (Sixth Circuit, 2019)
Antrim Pharmaceuticals LLC v. Bio-Pharm, Inc.
950 F.3d 423 (Seventh Circuit, 2020)
In re Puda Coal Securities Inc., Litigation
30 F. Supp. 3d 230 (S.D. New York, 2014)
Querub v. Hong Kong
649 F. App'x 55 (Second Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Jonathan Mayer v. ADCS Clinics, LLC, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/jonathan-mayer-v-adcs-clinics-llc-et-al-paed-2025.